269 related articles for article (PubMed ID: 19694360)
1. [The role of the pathologist in the management of gastrointestinal stromal tumors (GIST)].
Bouzourene H
Rev Med Suisse; 2009 Jul; 5(211):1505-8. PubMed ID: 19694360
[TBL] [Abstract][Full Text] [Related]
2. Pediatric KIT wild-type and platelet-derived growth factor receptor alpha-wild-type gastrointestinal stromal tumors share KIT activation but not mechanisms of genetic progression with adult gastrointestinal stromal tumors.
Janeway KA; Liegl B; Harlow A; Le C; Perez-Atayde A; Kozakewich H; Corless CL; Heinrich MC; Fletcher JA
Cancer Res; 2007 Oct; 67(19):9084-8. PubMed ID: 17909012
[TBL] [Abstract][Full Text] [Related]
3. Gastrointestinal stromal tumors with KIT exon 11 deletions are associated with poor prognosis.
Andersson J; Bümming P; Meis-Kindblom JM; Sihto H; Nupponen N; Joensuu H; Odén A; Gustavsson B; Kindblom LG; Nilsson B
Gastroenterology; 2006 May; 130(6):1573-81. PubMed ID: 16697720
[TBL] [Abstract][Full Text] [Related]
4. [c-Kit and PDGFRA mutations and clinico-morphological features of gastrointestinal stromal tumors].
Beliakov IS; Anurova OA; Snigur PV; Tsyganova IV; Sel'chuk VIu; Mazurenko NN
Vopr Onkol; 2007; 53(6):677-81. PubMed ID: 18416137
[TBL] [Abstract][Full Text] [Related]
5. KIT oncoprotein interactions in gastrointestinal stromal tumors: therapeutic relevance.
Zhu MJ; Ou WB; Fletcher CD; Cohen PS; Demetri GD; Fletcher JA
Oncogene; 2007 Sep; 26(44):6386-95. PubMed ID: 17452978
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of oncogenic KIT and PDGFRA mutations in gastrointestinal stromal tumours.
Lasota J; Miettinen M
Histopathology; 2008 Sep; 53(3):245-66. PubMed ID: 18312355
[TBL] [Abstract][Full Text] [Related]
7. Gastrointestinal stromal tumours: an update.
Rubin BP
Histopathology; 2006 Jan; 48(1):83-96. PubMed ID: 16359540
[TBL] [Abstract][Full Text] [Related]
8. Prognostic relevance of KIT and PDGFRA mutations in gastrointestinal stromal tumors.
Braggio E; Braggio Dde A; Small IA; Lopes LF; Valadão M; Gouveia ME; Moreira Ados S; Linhares E; Romano S; Bacchi CE; Renault IZ; Guimarães DP; Ferreira CG
Anticancer Res; 2010 Jun; 30(6):2407-14. PubMed ID: 20651400
[TBL] [Abstract][Full Text] [Related]
9. [Gastrointestinal stroma tumors (GIST): what is new in 2009?].
Emile JF; Scoazec JY; Coindre JM
Ann Pathol; 2009 Feb; 29(1):20-3. PubMed ID: 19233089
[TBL] [Abstract][Full Text] [Related]
10. Establishment and characterization of a human gastrointestinal stromal tumour (GIST) xenograft in athymic nude mice.
Revheim ME; Seierstad T; Berner JM; Bruland OS; Røe K; Ohnstad HO; Bjerkehagen B; Bach-Gansmo T
Anticancer Res; 2009 Nov; 29(11):4331-6. PubMed ID: 20032375
[TBL] [Abstract][Full Text] [Related]
11. Aberrant methylation status of known methylation-sensitive CpG islands in gastrointestinal stromal tumors without any correlation to the state of c-kit and PDGFRA gene mutations and their malignancy.
Saito K; Sakurai S; Sano T; Sakamoto K; Asao T; Hosoya Y; Nakajima T; Kuwano H
Cancer Sci; 2008 Feb; 99(2):253-9. PubMed ID: 18271923
[TBL] [Abstract][Full Text] [Related]
12. Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST).
Dematteo RP; Gold JS; Saran L; Gönen M; Liau KH; Maki RG; Singer S; Besmer P; Brennan MF; Antonescu CR
Cancer; 2008 Feb; 112(3):608-15. PubMed ID: 18076015
[TBL] [Abstract][Full Text] [Related]
13. [Therapeutic targets in gastrointestinal stromal tumors].
Wardelmann E; Schildhaus HU; Merkelbach-Bruse S; Büttner R
Verh Dtsch Ges Pathol; 2006; 90():73-9. PubMed ID: 17867582
[TBL] [Abstract][Full Text] [Related]
14. Gastrointestinal stromal tumors presenting as omental masses--a clinicopathologic analysis of 95 cases.
Miettinen M; Sobin LH; Lasota J
Am J Surg Pathol; 2009 Sep; 33(9):1267-75. PubMed ID: 19440146
[TBL] [Abstract][Full Text] [Related]
15. The analysis of status and clinical implication of KIT and PDGFRA mutations in gastrointestinal stromal tumor (GIST).
Du CY; Shi YQ; Zhou Y; Fu H; Zhao G
J Surg Oncol; 2008 Sep; 98(3):175-8. PubMed ID: 18618605
[TBL] [Abstract][Full Text] [Related]
16. Spectrum and prognostication of KIT and PDGFRA mutation in gastrointestinal stromal tumors.
Tzen CY; Wang MN; Mau BL
Eur J Surg Oncol; 2008 May; 34(5):563-8. PubMed ID: 17532173
[TBL] [Abstract][Full Text] [Related]
17. Differentially expressed proteins in gastrointestinal stromal tumors with KIT and PDGFRA mutations.
Kang HJ; Koh KH; Yang E; You KT; Kim HJ; Paik YK; Kim H
Proteomics; 2006 Feb; 6(4):1151-7. PubMed ID: 16402362
[TBL] [Abstract][Full Text] [Related]
18. Inherited predisposition to gastrointestinal stromal tumor.
Agarwal R; Robson M
Hematol Oncol Clin North Am; 2009 Feb; 23(1):1-13, vii. PubMed ID: 19248967
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibody DOG1.1 shows higher sensitivity than KIT in the diagnosis of gastrointestinal stromal tumors, including unusual subtypes.
Liegl B; Hornick JL; Corless CL; Fletcher CD
Am J Surg Pathol; 2009 Mar; 33(3):437-46. PubMed ID: 19011564
[TBL] [Abstract][Full Text] [Related]
20. An immunohistochemical and molecular study of gastrointestinal stromal tumours.
Teong YT; Teo ST; Tan LP; Wu BQ; Peh SC
Med J Malaysia; 2006 Dec; 61(5):526-33. PubMed ID: 17623951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]